These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1495 related articles for article (PubMed ID: 23051009)

  • 21. Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice.
    Song G; Zong C; Zhang Z; Yu Y; Yao S; Jiao P; Tian H; Zhai L; Zhao H; Tian S; Zhang X; Wu Y; Sun X; Qin S
    Free Radic Biol Med; 2015 Oct; 87():58-68. PubMed ID: 26117323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration.
    Huang H; Koelle P; Fendler M; Schröttle A; Czihal M; Hoffmann U; Conrad M; Kuhlencordt PJ
    Atherosclerosis; 2014 Jul; 235(1):213-22. PubMed ID: 24858340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.
    Semo J; Chernin G; Jonas M; Shimoni S; George J
    Lipids Health Dis; 2019 Dec; 18(1):208. PubMed ID: 31796057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro.
    Sinningen K; Rauner M; Goettsch C; Al-Fakhri N; Schoppet M; Hofbauer LC
    Biochem Biophys Res Commun; 2013 Jul; 437(2):314-8. PubMed ID: 23817038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
    van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
    PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
    Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
    George J; Afek A; Abashidze A; Shmilovich H; Deutsch V; Kopolovich J; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2636-41. PubMed ID: 16195475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50.
    Fang G; Song D; Ye X; Mao SZ; Liu G; Liu SF
    Am J Pathol; 2012 Nov; 181(5):1530-9. PubMed ID: 22940439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.
    Zhang T; Hu Q; Shi L; Qin L; Zhang Q; Mi M
    PLoS One; 2016; 11(12):e0167020. PubMed ID: 27907038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of macrophage transcription factor MafB in atherosclerotic plaque stability.
    Hasegawa H; Watanabe T; Kato S; Toshima T; Yokoyama M; Aida Y; Nishiwaki M; Kadowaki S; Narumi T; Honda Y; Otaki Y; Honda S; Shunsuke N; Funayama A; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Abe S; Shibata Y; Kubota I
    Atherosclerosis; 2016 Jul; 250():133-43. PubMed ID: 27214395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.